MedPath

Collaborative Efforts to Increase Flu Vaccination

Not Applicable
Completed
Conditions
Influenza
Collaboration
Interventions
Behavioral: Private/public collaboration to increase flu vaccination
Other: Usual care
Registration Number
NCT01403649
Lead Sponsor
University of Colorado, Denver
Brief Summary

Beginning with the 2009-2010 season, influenza vaccine is universally recommended for children age 6 months to 18 years old, placing extra burden on health care providers across the U.S. The focus of this study is to develop new strategies and implement existing evidence-based strategies to enhance influenza immunization in these children. The intervention will involve collaboration from different types of primary care providers, the Colorado Immunization Information System (CIIS), public health departments and visiting nursing services (VNA). It will be designed and implemented by those involved with delivery with a focus on sustainability after the completion of the study. Parental input will be gathered during the planning year through focus groups to assist in developing the intervention. Qualitative assessments and examination of processes during the first year of implementation will guide modifications during the second implementation year in order to assure sustainability. Primary outcome measures in the intervention and control groups: 1) increase in the rate of receipt of ≥1 influenza vaccine during the post-intervention year compared to the pre-intervention year among children 6 mo.-18 yr. and 2) increase in the rate of children 6 mo.-18 yr. who were fully immunized (received all required influenza injections) during the season. 3) measure outcomes by age group (6 mo.-5 yr., 6-8 yr., 9-12 yr., 13-18 yr.) and types of clinical sites (urban Peds, urban FM, rural FM)

Detailed Description

Specific Aim 1: Within each of three types of clinical sites (urban pediatric, urban family medicine, and rural family medicine) recruit a group of similar practices (Year 1) 1a. Randomize practices within each type of clinical site to either the intervention or the control group

1b. Establish private-public collaborations for influenza vaccination delivery between county public health departments, visiting nursing associations and each of the intervention practices within the three clinical site types

Specific Aim 2: Conduct focus groups among parents of children seen at intervention practices, to assess attitudes and perceived barriers to possible practice-based and collaborative strategies to promote influenza vaccination (Year 1)

Specific Aim 3: Develop (Year 1) and implement (Years 2 and 3) a plan for comprehensive and collaborative delivery of influenza vaccine at intervention practices 3a. Develop practice-based intervention strategies focusing primarily on immunization of high-risk patients 3b. Develop private-public collaborative interventions between the intervention practices, their county public health department and visiting nursing associations focusing primarily on immunization of school-aged children 3c. Implement (Years 2 and 3) both practice-based and private-public collaborative strategies in the intervention practices while monitoring only in the control practices

Specific Aim 4: Conduct a group-randomized trial to evaluate and compare the effectiveness of the comprehensive delivery model in improving influenza vaccination coverage for children 6 months to 18 years in three different types of clinical sites (urban pediatric, urban family medicine, and rural family medicine).

4a. Evaluate effectiveness of the comprehensive delivery model at each of the three types of clinical sites

1. Compare the following primary outcome measures in the intervention and control groups: 1) increase in the rate of receipt of ≥1 influenza vaccine during the post-intervention year compared to the pre-intervention year among children 6 months to 18 years and 2) increase in the rate of children 6 months to 18 years who were fully immunized (received all required influenza injections) during the season.

2. Compare the following secondary outcome measures: 1) increase in the rate of receipt of ≥1 influenza vaccine during the post-intervention year compared to the pre-intervention year among high-risk children and 2) increase in the rate of high-risk children who were fully immunized during the season.

3. Evaluate sustainability of the comprehensive delivery model on the above outcome measures

4b. Compare the effectiveness of the comprehensive delivery model in three different types of clinical sites (urban pediatric private practice, urban family medicine private practice, and rural family medicine private practice)

Specific Aim 5: Evaluate the process of implementation of the comprehensive delivery model for influenza delivery in each of the three types of sites.

5a. Assess process measures relevant to implementation of practice-based interventions and compare by type of clinical site 5b. Assess process measures relevant to implementation of private-public collaborative interventions and compare by type of clinical site 5c. Using key informant interviews, assess perceptions regarding facilitators and barriers to private-public collaborative delivery, alternative methods and means of improving the process among practice providers, administrators and among participating public health and visiting nurse personnel

Specific Aim 6: In two urban pediatric intervention practices and one rural family medicine practice, conduct surveys examining parental attitudes about methods of influenza delivery and their experience with their practice's participation in a comprehensive and collaborative private-public model for influenza delivery

Major Hypotheses:

SA4. Hypothesis 1. Effectiveness on receipt of ≥1 influenza vaccine: The increase in the likelihood of receiving ≥1 influenza vaccine during the post-intervention year compared to the pre-intervention year among children 6 months to 18 years will be greater for children in intervention practices than in control practices.

SA4. Hypothesis 2 Effectiveness - fully immunized: The increase in the likelihood of receiving all necessary influenza vaccines during the post-intervention year compared to the pre-intervention year among children 6 months to 18 years will be greater for children in intervention practices than in control practices.

SA4. Hypothesis 3. Effectiveness by age strata: The increase in the likelihood of receiving ≥1 influenza vaccine during the post-intervention year compared to the pre-intervention year among children in each of the following age strata will be greater in intervention than in control practices: 1) 6 months through 5 years; 2) 6 through 8 years; 3) 9 through 12 years; 4) 13 through 18 years.

SA4. Hypothesis 4. Effectiveness in high-risk children: The increase in the likelihood of receiving of ≥1 influenza vaccine during the post-intervention year compared to the pre-intervention year among high-risk children 6 months to 18 years will be greater for high-risk children in intervention practices than in control practices.

SA4. Hypothesis 5. Sustainability: The increase in the likelihood of receiving ≥1 influenza vaccine during the second post-intervention year compared to the pre-intervention year among children 6 months to 18 years will be greater for children in intervention practices than in control practices. (Sustainability will also be evaluated for other outcomes above.)

SA4. Hypothesis 6. Differential effectiveness by clinical site type: The increase in the likelihood of receiving of ≥1 influenza vaccine during the post-intervention year compared to the pre-intervention year among children 6 months to 18 years for intervention vs. controls will differ by clinical site type

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
117175
Inclusion Criteria
  • Children age 6 mo - 18 yr in up to 20 practices
Read More
Exclusion Criteria
  • Infants under the age of 6 mo or adults over the age of 18
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Increasing flu vaccinationPrivate/public collaboration to increase flu vaccinationCollect from billing records in the 10 intervention practice sites to test for an increase in the rate of receipt of ≥1 influenza vaccine during the post-intervention year compared to the pre-intervention year among children 6 months to 18 years during the season. The interventions include: 1. Develop practice-based intervention strategies (like use of reminder-recall of children due for influenza,2. Develop Private/public collaboration to increase flu vaccination between the intervention practices, their county public health department and visiting nursing associations, and 3. Implement both practice-based and private-public collaborative strategies in the intervention practices while monitoring only in the control practices
Usual careUsual carePatients in control practices will continue to receive usual care with no change in practice regarding influenza immunization delivery.
Primary Outcome Measures
NameTimeMethod
Evaluate the effectiveness of collaborations between public and private entities to increase influenza vaccination in children 6 mos to 18 yrs in 10 intervention sites in 3 counties throughout the state of CO during the '10-11 & '11-12 flu seasons.Up to 4 months post intervention (December 2012)

Primary outcome measure is to increase the rate of receipt of ≥1 influenza vaccine during the post-intervention year(s) compared to the pre-intervention year among children 6 mos.-18 yrs in 10 intervention sites. Intervention practices will collaborate with their respective health departments and/or the VNA to help assist with the increase in volume of patients needing to be vaccinated against flu in the 2010-2011 and the 2011-2012 flu seasons. Billing data will be obtained from all 20 sites (intervention+control) and compared to evaluate the effectiveness of this collaboration.

Secondary Outcome Measures
NameTimeMethod
high-risk children receipt of influenza vaccinationbaseline and intervention years 1 and 2

increase in the rate of receipt of ≥1 influenza vaccine during the post-intervention year compared to the pre-intervention year among high-risk children

high-risk children fully immunized during influenza seasonbaseline and intervention years 1 and 2

increase in the rate of high-risk children who were fully immunized during the season.

Trial Locations

Locations (27)

Aurora Family Medicine

🇺🇸

Aurora, Colorado, United States

Forum Family Medicine

🇺🇸

Aurora, Colorado, United States

Indian Crest Pediatrics

🇺🇸

Broomfield, Colorado, United States

Tri County Health dept

🇺🇸

Aurora, Colorado, United States

Centennial Pediatrics

🇺🇸

Centennial, Colorado, United States

Premier Pediatrics

🇺🇸

Brighton, Colorado, United States

Advanced Pediatrics

🇺🇸

Centennial, Colorado, United States

Greenwood Pediatrics

🇺🇸

Centennial, Colorado, United States

Family Practice Clinic

🇺🇸

Ft. Morgan, Colorado, United States

Pediatric Pathways

🇺🇸

Centennial, Colorado, United States

CIIS

🇺🇸

Denver, Colorado, United States

Pediatrics 5280

🇺🇸

Centennial, Colorado, United States

Hampden Medical Group

🇺🇸

Englewood, Colorado, United States

Ft. Morgan Medical Group

🇺🇸

Ft. Morgan, Colorado, United States

Valley Medical Center

🇺🇸

Julesburg, Colorado, United States

Jefferson County Health dept

🇺🇸

Lakewood, Colorado, United States

Haxtun Family Medicine

🇺🇸

Haxtun, Colorado, United States

Kids First

🇺🇸

Lakewood, Colorado, United States

Denver West Pediatrics

🇺🇸

Lakewood, Colorado, United States

Lone Tree Family Medicine

🇺🇸

Lone Tree, Colorado, United States

Crown Point Pediatrics

🇺🇸

Parker, Colorado, United States

Pediatrics West

🇺🇸

Wheat Ridge, Colorado, United States

Yuma Clinic

🇺🇸

Yuma, Colorado, United States

Focus on Kids

🇺🇸

Littleton, Colorado, United States

Northeast County Health Dept

🇺🇸

Sterling, Colorado, United States

Mountain Land Pediatrics

🇺🇸

Thornton, Colorado, United States

Wray Clinic

🇺🇸

Wray, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath